Duke offers a one-year Otology and Neurotology/Skull Base Surgery Fellowship that provides structured clinical opportunities for trainees to develop advanced skills in otology, neurotology, and skull base surgery. The trainee will gain competency in otology and neurotology/lateral skull base procedures at the main Duke University Hospital in Durham, at Duke Raleigh Hospital, at a satellite ambulatory surgery center, and at the Durham Veterans Affairs Medical Center.

A robust experience in lateral skull base pathology (vestibular schwannomas, meningiomas, CSF leaks), vestibular surgery (superior canal dehiscence repair, labyrinthectomy/endolymphatic sac decompression), cochlear implantation in both adults and children and a vast opportunity for chronic ear surgery is provided. 

A meaningful, supervised research experience will be encouraged to enhance the clinical experience. Our fellows will gain practical experience in teaching residents at all of the Duke locations and the Durham VA hospital and have opportunities to participate in research that pushes the limits of knowledge in our field. The majority of time will be spent at the main campus (Duke University Hospital) in Durham, NC, as well as at the Davis Ambulatory Surgery Center in Durham, NC. The fellow will rotate with Dr. Calhoun Cunningham at Duke Raleigh Hospital (both operating rooms and clinics). In addition, both domestic and international fellows will have their own independent full-day clinic, twice per month, at a new state-of-the-art otolaryngology satellite clinic in Cary, NC. 

Domestic fellows will be expected to participate in faculty call, which is split among the 15+ full-time faculty at Duke University Hospitals. 

Please note that our department was recently granted accredidation of a two-year ACGME Neurotology fellowship, with the first fellow to start in July of 2027, and recruitment to begin in the Spring of 2026. 

Currently, we are soliciting applications for our one-year fellowship, which will begin July 1, 2026, and end June 30, 2027.